Furthermore, the re-establishment of SLC22A18 methylation status and the recovery of its expression levels in vitro inhibited cell proliferation by increasing the apoptosis rate and blocking cell growth and adhesion, while in vivo assays showed decreased tumor growth [31,32]. The gene discussed is SLC67A1; the disease is neoplasm.